Value-Based Contracting
Expert articles and analysis related to value-based contracting.
AI Summary — Last 30 Days
CMS under the Trump administration is pushing a more explicit ACO-first Medicare strategy, with proposed physician payment and MSSP changes aimed at expanding accountable care participation, reducing reliance on MIPS, and reshaping referral economics for home-based and specialty partners. At the same time, CMMI’s new and evolving models—especially LEAD and CJR-X—are forcing providers to make near-term portfolio decisions between MSSP, enhanced longitudinal ACO risk, and episode-based contracting, while awaiting key financial methodology details that will determine downside-risk exposure and capital needs (Wakely on LEAD risk strategy). The policy backdrop is increasingly focused on fiscal accountability: agilon’s reported 2024 ACO REACH savings underscore the strategic value of physician-led risk models, while scrutiny of CMMI trust fund impacts and Medicare Advantage coding intensity signals tighter expectations for measurable savings, payment accuracy, and defensible risk adjustment across VBC contracts (agilon ACO REACH results).
Related Articles
Hospitals irate after Eli Lilly follows through on 340B ultimatum
The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last week. Hospitals are urging HRSA to step in.
Rethinking Downside Risk: The Role of Stop Loss in ACO Contracts
Rethinking Downside Risk: The Role of Stop Loss in ACO Contracts Wakely
Why specialists are the key players in the next phase of value-based care
Why specialists are the key players in the next phase of value-based care Medical Economics
Why specialists are the key players in the next phase of value-based care
How Electronic Patient-Reported Outcomes Are Transforming Symptom Management and Value-Based Cancer Care
How Electronic Patient-Reported Outcomes Are Transforming Symptom Management and Value-Based Cancer Care HMP Global Learning Network
Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts
Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts MedCity News
Health services M&A is active in 2026, but uncertainty slows volume: PwC
Buyers are being more selective amid heightened policy and reimbursement pressure in healthcare, according to the analysis. Still, deal value is up compared to the first half of 2025.
Trump targets Germany over drug prices: 5 notes
Trump targets Germany over drug prices: 5 notes Becker's Hospital Review
Interwell Health delivers savings, top quality scores in Kidney Care Choices Model
Interwell Health delivers savings, top quality scores in Kidney Care Choices Model McKnights Home Care
Pearl Health Advances AI Analytics Strategy and Mission-Driven Hiring Focus in Value-Based Care Push
Pearl Health Advances AI Analytics Strategy and Mission-Driven Hiring Focus in Value-Based Care Push TipRanks